Literature DB >> 15982867

The emerging family of hepatoblastoma tumours: from ontogenesis to oncogenesis.

Arthur Zimmermann1.   

Abstract

The identification of distinct types and subtypes of hepatoblastoma has led to a successful classification of these lesions. In recent years, and particularly within large tumour trials, the spectrum of paediatric epithelial liver tumours has increased. This, together with the need for defining clinically relevant risk groups, will require a new approach to defining and classifying these cancers. Furthermore, an impressive amount of molecular biological information on liver ontogenesis and growth regulation of hepatic tumours has recently accumulated, which will allow the development of a comprehensive classification system with particular emphasis on prognostics. In this review, novel findings relating to these issues are discussed.

Entities:  

Mesh:

Year:  2005        PMID: 15982867     DOI: 10.1016/j.ejca.2005.02.035

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  23 in total

1.  β-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma.

Authors:  Sharada Mokkapati; Katharina Niopek; Le Huang; Kegan J Cunniff; E Cristy Ruteshouser; Mark deCaestecker; Milton J Finegold; Vicki Huff
Journal:  Cancer Res       Date:  2014-05-21       Impact factor: 12.701

2.  Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer.

Authors:  Stefano Cairo; Yipeng Wang; Aurélien de Reyniès; Karine Duroure; Jennifer Dahan; Marie-José Redon; Monique Fabre; Michael McClelland; Xin W Wang; Carlo M Croce; Marie-Annick Buendia
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

3.  Regulatory network analysis of genes and microRNAs in human hepatoblastoma.

Authors:  Jimin He; Xiaoxin Guo; Linlin Sun; Ning Wang; Jiwei Bao
Journal:  Oncol Lett       Date:  2016-09-27       Impact factor: 2.967

Review 4.  The Wnt/β-catenin signaling pathway in liver biology and disease.

Authors:  Jaideep Behari
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2010-12       Impact factor: 3.869

Review 5.  Hepatoblastoma: an oncological review.

Authors:  Derek J Roebuck; Giorgio Perilongo
Journal:  Pediatr Radiol       Date:  2006-01-11

6.  Hepatoblastoma: a single institutional experience of 18 cases.

Authors:  Parul J Shukla; Savio G Barreto; Sajid S Qureshi; Rohini Hawaldar; Shailesh V Shrikhande; Mukta R Ramadwar; Shripad Banavali
Journal:  Pediatr Surg Int       Date:  2008-05-06       Impact factor: 1.827

Review 7.  The SPLIT research agenda 2013.

Authors:  Estella M Alonso; Vicky L Ng; Ravinder Anand; Christopher D Anderson; Udeme D Ekong; Emily M Fredericks; Katryn N Furuya; Nitika A Gupta; Stacee M Lerret; Shikha Sundaram; Greg Tiao
Journal:  Pediatr Transplant       Date:  2013-05-30

8.  Delta-like protein (DLK) is a novel immunohistochemical marker for human hepatoblastomas.

Authors:  Katalin Dezso; Judit Halász; Hanne Cathrine Bisgaard; Sándor Paku; Eszter Turányi; Zsuzsa Schaff; Peter Nagy
Journal:  Virchows Arch       Date:  2008-01-31       Impact factor: 4.064

9.  Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways.

Authors:  Adekunle M Adesina; Dolores Lopez-Terrada; Kwong K Wong; Preethi Gunaratne; Yummy Nguyen; Joseph Pulliam; Judith Margolin; Milton J Finegold
Journal:  Hum Pathol       Date:  2009-02-05       Impact factor: 3.466

10.  Pharmacological inhibition of beta-catenin in hepatoblastoma cells.

Authors:  V Ellerkamp; J Lieber; C Nagel; J Wenz; S W Warmann; J Fuchs; S Armeanu-Ebinger
Journal:  Pediatr Surg Int       Date:  2012-12-25       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.